Corporate insider profile
Paul Peter Tak Insider Trades
Latest reported as Chief Executive Officer of Candel Therapeutics, Inc. (CADL).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$3,160,771.26
- Latest transaction
- Sep 11, 2026
Affiliated corporations
Reported company relationships
Transaction history
